Skip to content

HATTERAS VENTURE PARTNERS

HATTERAS VENTURE PARTNERS is a Pre-seed, Seed and Series A fund in North Carolina and Southeastern United States writing $500K–$5M checks into Healthcare, biopharmaceuticals, medical-devices, diagnostics, life-sciences and healthcare-it.

Stages
Pre-seed, Seed, Series A
Sectors
Healthcare, biopharmaceuticals, medical-devices, diagnostics, life-sciences, healthcare-it
Check size
$500K–$5M
Invests in
North Carolina, Southeastern United States
Round role
Leads rounds
Actively investing
Yes
Founded
2000
Assets under management
$900M

Thesis

Hatteras Venture Partners focuses on life sciences and healthcare, specifically biopharmaceuticals, medical devices, diagnostics, and healthcare IT. They invest in seed and early-stage companies, including pre-seed, seed, seed-plus, and Series A stages, primarily in the Southeastern United States, with a focus on North Carolina, while also co-investing nationally. Hatteras often acts as a lead investor, emphasizing a "replicable, risk-mitigated value-creation model". They provide capital and hands-on support for team recruitment, business development, regulatory planning, and portfolio strategy. The firm manages over $900 million across multiple funds, including Hatteras Venture Partners VII and Hatteras Opportunity Fund I, which closed with over $200 million in capital commitments.

Common questions

Does HATTERAS VENTURE PARTNERS invest at the Pre-seed stage?

Yes. HATTERAS VENTURE PARTNERS lists Pre-seed, Seed and Series A among the stages it invests in.

What check size does HATTERAS VENTURE PARTNERS write?

HATTERAS VENTURE PARTNERS writes $500K–$5M checks.

Where does HATTERAS VENTURE PARTNERS invest?

HATTERAS VENTURE PARTNERS invests in North Carolina and Southeastern United States.

Related lists